Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Grade”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07404293
What this trial is testing

Zero CDE Technique for Lens Removal During FLACS

Who this might be right for
Cataract With a Nuclear Sclerosis Grade Between 1 to 3
Bochner Eye Institute 90
Not applicableLooking for participantsNCT06261866
What this trial is testing

Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary Syndrome

Who this might be right for
Chronic Coronary Syndrome
Medical University of Warsaw 200
Not applicableStudy completedNCT06556056
What this trial is testing

An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

Who this might be right for
Androgenic Alopecia
NovoBliss Research Pvt Ltd 108
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT03927222
What this trial is testing

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Who this might be right for
Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 6
Not applicableStudy completedNCT04461002
What this trial is testing

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

Who this might be right for
Glioma
GCS Ramsay Santé pour l'Enseignement et la Recherche 22
Testing effectiveness (Phase 2)Study completedNCT00003110
What this trial is testing

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT03010358
What this trial is testing

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

Who this might be right for
AnemiaB-Cell Prolymphocytic LeukemiaGrade 1 Follicular Lymphoma+11 more
Alexey Danilov, MD 24
Not applicableUnknownNCT06333743
What this trial is testing

Laser Ablation in the Treatment of High-grade Cervical Lesions

Who this might be right for
High-Grade Squamous Intraepithelial Lesions
Peking Union Medical College Hospital 308
Early research (Phase 1)Ended earlyNCT00019708
What this trial is testing

Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNon-Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 45
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Not applicableStudy completedNCT05709158
What this trial is testing

Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

Who this might be right for
Breast Cancer
Pfizer 4,184
Very early researchStudy completedNCT05095350
What this trial is testing

Effect of Probiotics on Primary Hypertension

Who this might be right for
Hypertension
Chinese Academy of Medical Sciences, Fuwai Hospital 115
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Early research (Phase 1)WithdrawnNCT02698293
What this trial is testing

PDT Plus Vitamin D3 for Anal Dysplasia

Who this might be right for
Anal DysplasiaCarcinoma in Situ
Abramson Cancer Center at Penn Medicine
Post-approval studies (Phase 4)Ended earlyNCT03821376
What this trial is testing

Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

Who this might be right for
Renal Malignant Tumor
Indiana University 12
Testing effectiveness (Phase 2)Study completedNCT00148109
What this trial is testing

Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

Who this might be right for
Sarcoma
University of Michigan Rogel Cancer Center 36
Not applicableUnknownNCT05858021
What this trial is testing

COrSIcA: Disease Measurement

Who this might be right for
Anal Intraepithelial NeoplasiaAnal High-grade Squamous Intraepithelial LesionAnal HSIL
David Finch 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03504163
What this trial is testing

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00003621
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 29
Next Page